Based on our advanced algorithm, we have generated comprehensive BBOT stock price predictions for multiple time horizons. Our models indicate potential volatility in the short term, with specific targets calculated for the 1-day and 1-week outlooks.
Looking further ahead, our analysts have pinpointed significant trend shifts in the longer-term data. We have exclusive projections available for the 1-month forecast, a detailed 2026 projection, and a long-range 2030 forecast that reveals potential upside or downside risks.
Unlock the full analysis to access these precise price targets and see exactly where our models predict BBOT is heading. Stay informed and make strategic decisions with our premium data-driven insights!

Swing
Stock Price Below SMA_5
Short Term
SMA_5 Above SMA_20
Mid Term
SMA_20 Below SMA_60
Long Term
SMA_60 Above SMA_200
The radar chart shows that buying BridgeBio Oncology Therapeutics Inc (BBOT) stock in September has the highest probability of a positive return (100.00%), while January has the lowest probability (0.00%).
BBOT's stock price rose by 26.46% in 2025,decreased by -28.56% in 2026, and went by in
Bullish technical signals of BBOT include: AO_5_34 > 0, MOM_10 > 0.
Bearish technical signals of BBOT include: MACD_12_26_9 < 0, 5-day SMA crosses below 10-day SMA.
BBOT has 2 buy signals and 2 sell signals now. Overall the technical rating for BBOT is Neutral. Note that market conditions change all the time. In addition to technical ratings, keep an eye on the Valuation Level of BBOT
BridgeBio Oncology Therapeutics Inc's overall moving average trend leans more bearish as of April 26 2026, with 3 negative signals and 1 positive signal.
The price prediction chart for BridgeBio Oncology Therapeutics Inc (BBOT.O) stock, as of April 19 2026, forecasts a 0.98%% change over the next month, based on its high correlation with SOTK stock patterns. The similarity between their price movements over the analyzed periods is 93.41%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
In , BridgeBio Oncology Therapeutics Inc's value is forecasted to reach an average price of $NaN. The price is predicted to fluctuate between a low of $NaN and a high of $NaN.
In , BridgeBio Oncology Therapeutics Inc's value is forecasted to reach an average price of $NaN. The price is predicted to fluctuate between a low of $NaN and a high of $NaN.